Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ethicon adds new platform to surgical offerings

This article was originally published in Clinica

Executive Summary

In a bid to expand its surgical device portfolio, Ethicon Endo-Surgery has inked a deal to acquire privately-held SurgRx and its family of FDA-cleared EnSeal devices. The systems incorporate Redwood, California-based SurgRx's proprietary advanced bipolar tissue sealing technology, which combines high compression and controlled energy delivery to create strong vessel seals. Ethicon, a Johnson & Johnson company, said that the EnSeal will complement its current Harmonic line of ultrasonic devices used in open and laparoscopic procedures. Financial terms of the deal were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel